Scholarlink

<p>Infectious bronchitis virus (IBV) is a highly contagious gammacoronavirus that causes disease in chickens, typically presenting with respiratory signs but in some cases affecting the reproductive or renal systems. Due to different antigenic variants co-circulating in poultry with limited availability of homologous vaccines, producers have historically combined different vaccine types to provide a broader cross-protective immunity. This study evaluated whether two USDA licensed vaccines (vGA08 and Mass types—administered simultaneously at one day of age) can protect against challenge with 4 different currently circulating variant IBV strains in the US and Canada (PA/1220/98, CA/1737/04, NC/DARK/23, and Canada/DMV1639/23) at 4&#xa0;weeks of age. For the vaccinated/challenged birds, clinical signs were reduced and the level of challenge virus detected was significantly lowered for each of the challenge viruses compared to non-vaccinated birds challenged with the same virus. This study is important because it provides poultry veterinarians with information on the level protection that can be expected using safe and efficacious commercially licensed vaccines against 4 currently circulating variant IBV strains.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Cross-protection studies using vGA08 and Mass type IBV vaccines against four different antigenic variant viruses currently circulating in poultry in the USA and Canada

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月15日

查看全文
  • Mark W. Jackwood,
  • Robert Beckstead,
  • Jimmy White,
  • Adrian Bustamante,
  • Sean Brimer,
  • Marshall Putnam

摘要

Infectious bronchitis virus (IBV) is a highly contagious gammacoronavirus that causes disease in chickens, typically presenting with respiratory signs but in some cases affecting the reproductive or renal systems. Due to different antigenic variants co-circulating in poultry with limited availability of homologous vaccines, producers have historically combined different vaccine types to provide a broader cross-protective immunity. This study evaluated whether two USDA licensed vaccines (vGA08 and Mass types—administered simultaneously at one day of age) can protect against challenge with 4 different currently circulating variant IBV strains in the US and Canada (PA/1220/98, CA/1737/04, NC/DARK/23, and Canada/DMV1639/23) at 4 weeks of age. For the vaccinated/challenged birds, clinical signs were reduced and the level of challenge virus detected was significantly lowered for each of the challenge viruses compared to non-vaccinated birds challenged with the same virus. This study is important because it provides poultry veterinarians with information on the level protection that can be expected using safe and efficacious commercially licensed vaccines against 4 currently circulating variant IBV strains.